About
Cūrza develops novel small-molecule antibiotics targeting drug-resistant bacterial infections, including ESKAPE pathogens and biofilm-related infections, focusing on new classes of ribosomal and antibiofilm antibiotics.
Explore Cūrza's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.